Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
110.50    0.00 (0.00%)
Bid:
109.00
Ask:
112.00
Spread: 3.00 (2.752%)
Market Cap: £66.48m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Further US Government Win

19 Dec 2006 11:33

Intercede Group PLC19 December 2006 19 DECEMBER 2006 INTERCEDE GROUP PLC ("Intercede" or "the Company") Further US Federal Government Win Intercede is delighted to inform the market that RSA Security Inc., has beenawarded a contract by the US Government's General Services Adminstration (GSA),to provide RSA Card Manager to an unnamed Federal Agency in support of theirHomeland Security Presidential Directive 12 (HSPD-12) compliance. RSA CardManager is powered by Intercede's MyID technology, under an OEM licenceagreement announced in 2005. This order was placed by GSA on behalf of asignificant +100,000 person independent federal agency, not previously announcedby Intercede. GSA Award Notice http://www.fbo.gov/spg/GSA/FTS/ASD3TS/Awards/GST0307DSC3001.html values this contract at $952,977. Under the terms ofIntercede's OEM contract with RSA, Intercede will receive an agreed percentageof this contract value. Although the contract has only recently been awarded, RSA Card Manager was usedto issue a HSPD-12 credential to the Commissioner of the Agency concerned onWednesday October 18, 2006, in advance of the mandated October 27, 2006deadline. Richard Parris, Chairman & Chief Executive of Intercede, commented: "Intercede are delighted that RSA Security have been selected to provide a MyIDpowered solution to this important Agency. This announcement demonstrates thatMyID has the flexibility and scalability to be deployed in a large FederalAgency where multiple technologies and solutions have been integrated to deliveran end-to-end capability." About HSPD-12 HSPD-12 is one of the most important and high profile security directives ofrecent years. It was issued by President Bush himself in August 2004 andrequired, firstly, the creation of an official federal standard (FIPS-201) forPersonal Identity Verification (PIV), which would prescribe technologies andprocesses for the effective vetting and access control of all federal employeesand contractors. The second requirement of HSPD-12 was for every US FederalAgency to have implemented a PIV solution by the end of October 2006, with allemployees and contractors required to have a personal-201 compliant, smart cardbased identity card one year later. Each of these cards will be issued andmanaged using a management system such as MyID. All HSPD-12 solutions must by mandate only incorporate products that have beenexhaustively tested against by the US General Services Administration (GSA), andincluded in the GSA's Approved Product List for PIV products. Intercedeannounced on October 4, 2006 that it had become the first product in itscategory to achieve this coveted status. It is estimated that almost 8 million identity cards will be issued underHSPD-12. Industry analysts Stanford Group estimate the total value of theprogramme to be worth approximately US$1.3 billion. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). Intercede's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates and Open Platformapplets. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology including: Athena Smartcard Solutions,Gemalto, Oberthur Card Systems, RSA Security, SafeNet, Thales, VeriSign and avariety of systems integrators and other security product and service providers. Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. For more information visit http://www.intercede.com ENQUIRIESIntercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public RelationsArchie Berens Tel. +44 (0)20 7743 6679Kate Catchpole Tel. +44 (0)7803 033 43 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.